Clinical review: Osteoporosis after solid organ transplantation

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 4, 2005, Pages 2456-2465

  Maalouf, Naim M ^a   Shane, Elizabeth ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AZATHIOPRINE; CALCITONIN; CALCIUM; CYCLOSPORIN A; ETIDRONIC ACID; GLUCOCORTICOID; IBANDRONIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PAMIDRONIC ACID; PARATHYROID HORMONE; RAPAMYCIN; TACROLIMUS; VITAMIN D; ZOLEDRONIC ACID; CALCINEURIN; IMMUNOSUPPRESSIVE AGENT;

CONGESTIVE HEART FAILURE; DIET SUPPLEMENTATION; HEPATIC OSTEODYSTROPHY; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LUNG DISEASE; MALNUTRITION; MORPHOMETRICS; ORGAN TRANSPLANTATION; OSTEODYSTROPHY; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; REVIEW; RISK FACTOR; BLOOD; BONE DENSITY; DRUG ANTAGONISM; METABOLISM;

BONE DENSITY; CALCINEURIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES; ORGAN TRANSPLANTATION; OSTEOPOROSIS; PARATHYROID HORMONE; RENAL OSTEODYSTROPHY; VITAMIN D;

EID: 17844410337     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1978     Document Type: Review

References (137)

1. 2003 Annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1993-2002. Table 1-2: DHHS/HSRA/OSP/DOT, Rockville, MD; UNOS, Richmond, VA; URREA, Ann Arbor, MI
2. Cohen A, Shane E 2003 Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int 14:617-630
3. Compston JE 2003 Osteoporosis after liver transplantation. Liver Transplant 9:321-330
4. Ninkovic M, Love SA, Tom B, Alexander GJ, Compston JE 2001 High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 69:321-326
5. Bjoro K, Brandsaeter B, Wiencke K, Bjoro T, Godang K, Bollerslev J, Schrumpf E 2003 Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. Scand J Gastroenterol 38:320-327
6. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodes J, Munoz-Gomez J 1997 Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 60:148-154
7. Floreani A, Newton JL, James OFW, Bassendine MF, Jones DEJ 2002 Osteoporosis is not a specific complication of primary biliary cirrhosis. Gut 50:898
8. American Gastroenterological Association 2003 Medical position statement: osteoporosis in hepatic disorders. Gastroenterology 125:937-940
9. Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S 1989 Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 96:213-221
10. Guichelaar MM, Malinchoc M, Sibonga J, Clarke BL, Hay JE 2002 Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry. Hepatology 36:895-903
11. Cuthbert JA, Pak CY, Zerwekh JE, Glass KD, Combes B 1984 Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4:1-8
12. Diez A, Puig J, Serrano S, Marinoso ML, Bosch J, Marrugat J, Mellibovsky L, Nogues X, Knobel H, Aubia J 1994 Alcohol-induced bone disease in the absence of severe chronic liver damage. J Bone Miner Res. 9:825-831
13. Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D 1998 Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 28:695-699
14. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL 1995 Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95:2581-2586
15. Floreani A, Mega A, Tizian L, Burra P, Boccagni P, Baldo V, Fagiuoli S, Naccarato R, Luisetto G 2001 Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study. Osteoporos Int 12:749-754
16. Compston JE, Thompson RP 1977 Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet 1:721-724
17. Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L 1996 Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 101:262-269
18. Aris RM, Neuringer IP, Weiner MA, Egan TM, Ontjes D 1996 Severe osteoporosis before and after lung transplantation. Chest 109:1176-1183
19. Ferrari SL, Nicod LP, Hamacher J, Spiliopoulos A, Slosman DO, Rochat T, Bonjour JP, Rizzoli R 1996 Osteoporosis in patients undergoing lung transplantation. Eur Respir J 9:2378-2382
20. Gluck O, Colice G 2004 Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases. Chest 125:1859-1876
21. Aris RM, Renner JB, Winders AD, Buell HE, Riggs DB, Lester GE, Ontjes DA 1998 Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 128:186-193
22. Ionescu AA, Nixon LS, Evans WD, Stone MD, Lewis-Jenkins V, Chatham K, Shale DJ 2000 Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 162:789-794
23. Lark RK, Lester GE, Ontjes DA, Blackwood AD, Hollis BW, Hensler MM, Aris RM 2001 Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. Am J Clin Nutr 73:602-606
24. Haworth CS, Selby PL, Webb AK, Dodd ME, Musson H, McL Niven R, Economou G, Horrocks AW, Freemont AJ, Mawer EB, Adams JE 1999 Low bone mineral density in adults with cystic fibrosis. Thorax 54:961-967
25. Haworth CS, Webb AK, Egan JJ, Selby PL, Hasleton PS, Bishop PW, Freemont TJ 2000 Bone histomorphometry in adult patients with cystic fibrosis. Chest 118:434-439
26. Elkin SL, Vedi S, Bord S, Garrahan NJ, Hodson ME, Compston JE 2002 Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis. Am J Respir Crit Care Med 166:1470-1474
27. Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Caminiti M, Brown SA, Renner JB, Chalermskulrat W, Lester GE 2002 Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int 13:151-157
28. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V, McMahon DJ 1997 Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 103:197-207
29. Lee AH, Mull RL, Keenan GF, Callegari PE, Dalinka MK, Mancini DM, DiSesa VJ, Attie MF 1994 Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 96:35-41
30. Pisani B, Mullen GM 2002 Prevention of osteoporosis in cardiac transplant recipients. Curr Opin Cardiol 17:160-164
31. Elder G 2002 Pathophysiology and recent advances in the management of renal osteodystrophy. J Bone Miner Res 17:2094-2105
32. Hruska KA, Teitelbaum SL 1995 Renal osteodystrophy. N Engl J Med 333:166-175
33. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T 1999 Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287-293
34. Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C 2000 Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396-399
35. Stehman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heckbert SR, Wong CS, Ball A, Weiss NS 2000 Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58:2200-2205
36. Canalis E 1996 Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447
37. Suzuki Y, Ichikawa Y, Saito E, Homma M 1983 Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32:151-156
38. Kimberg DV, Baerg RD, Gershon E, Graudusius RT 1971 Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest 50:1309-1321
39. Sakakura M, Takebe K, Nakagawa S 1975 Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 40:774-779
40. Chrousos GP, Torpy DJ, Gold PW 1998 Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications. Ann Intern Med 129:229-240
41. Canalis E, Delany AM 2002 Mechanisms of glucocorticoid action in bone. Ann NY Acad Sci 966:73-81
42. Weinstein RS, Jilka RL, Parfitt MA, Manolagas SC 1998 Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274-282
43. Danneskiold-Samsoe B, Grimby G 1986 The influence of prednisone on the muscle morphology and muscle enzymes in patients with rheumatoid arthritis. Clin Sci 71:693-701
44. Matsuda S, Koyasu S 2000 Mechanisms of action of cyclosporine. Immunopharmacology 47:119-125
45. Epstein S 1996 Post-transplantation bone disease: the role of immunosuppressive agents on the skeleton. J Bone Miner Res 11:1-7
46. Schlosberg M, Movsowitz C, Epstein S, Ismail F, Fallon MD, Thomas S 1989 The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 124:2179-2184
47. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S 1988 Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 123:2571-2577
48. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM 1996 Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 50:1089-1100
49. Epstein S, Dissanayake IR, Goodman GR, Bowman AR, Zhou H, Ma Y, Jee WS 2001 Effect of the interaction of parathyroid hormone and cyclosporine A on bone mineral metabolism in the rat. Calcif Tissue Int 68:240-247
50. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodes J, Munoz-Gomez J 2001 Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif Tissue Int 68:83-86
51. Dissanayake IR, Goodman GR, Bowman AR, Ma Y, Pun S, Jee WS, Epstein S 1998 Mycophenolate mofetil: a promising new immunosuppressant that does not cause bone loss in the rat. Transplantation 65:275-278
52. Joffe I, Katz I, Sehgal S, Bex F, Kharode Y, Tamasi J, Epstein S 1993 Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats. Calcif Tissue Int 53:45-52
53. Bryer HP, Isserow JA, Armstrong EC, Mann GN, Rucinski B, Buchinsky FJ, Romero DF, Epstein S 1995 Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat. J Bone Miner Res 10:132-138
54. Vintro AQ, Krasnoff JB, Painter P 2002 Roles of nutrition and physical activity in musculoskeletal complications before and after liver transplantation. AACN Clin Issues 13:333-347
55. Kwan JT, Almond MK, Evans K, Cunningham J 1992 Changes in total body bone mineral content and regional bone mineral density in renal patients following renal transplantation. Miner Electrolyte Metab 18:166-168
56. Shane E, Rivas M, McMahon DJ, Staron RB, Silverberg SJ, Seibel MJ, Mancini D, Michler RE, Aaronson K, Addesso V, Lo SH 1997 Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 82:1497-1506
57. Madersbacher S, Ludvik G, Stulnig T, Grunberger T, Maier U 1996 The impact of liver transplantation on endocrine status in men. Clin Endocrinol (Oxf) 44:461-466
58. Laifer SA, Guido RS 1995 Reproductive function and outcome of pregnancy after liver transplantation in women. Mayo Clin Proc 70:388-394
59. Mass K, Quint EH, Punch MR, Merion RM 1996 Gynecological and reproductive function after liver transplantation. Transplantation 62:476-479
60. Saha MT, Saha HH, Niskanen LK, Salmela KT, Pasternack AI 2002 Time course of serum prolactin and sex hormones following successful renal transplantation. Nephron 92:735-737
61. Akbari F, Alavi M, Esteghamati A, Mehrsai A, Djaladat H, Zohrevand R, Pourmand G 2003 Effect of renal transplantation on sperm quality and sex hormone levels. Br J Urol Int 92:281-283
62. Feller RB, McDonald JA, Sherbon KJ, McCaughan GW 1999 Evidence of continuing bone recovery at a mean of 7 years after liver transplantation. Liver Transplant Surg 5:407-413
63. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM 2003 Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349:931-940
64. Julian B, Queries L, Niemann K 1992 Musculoskeletal complications after renal transplantation: Pathogenesis and treatment. Am J Kidney Dis 19:99-120
65. Sperschneider H, Stein G 2003 Bone disease after renal transplantation. Nephrol Dial Transplant 18:874-877
66. Torres A, Lorenzo V, Salido E 2002 Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 13:551-558
67. Torres A, Rodriguez AP, Concepcion MT, Garcia S, Rufino M, Martin B, Perez L, Machado M, de Bonis E, Losada M, Hernandez D, Lorenzo V 1998 Parathyroid function in long-term renal transplant patients: importance of pre-transplant PTH concentrations. Nephrol Dial Transplant 13(Suppl 3):94-97
68. Montalban C, de Francisco AL, Marinoso ML, Zubimendi JA, Garcia Unzueta M, Amado JA, Arias M 2003 Bone disease in long-term adult kidney transplant patients with normal renal function. Kidney Int 63(Suppl 85):129-132
69. Reinhardt W, Bartelworth H, Jockenhovel F, Schmidt-Gayk H, Witzke O, Wagner K, Heemann UW, Reinwein D, Philipp T, Mann K 1998 Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 13:434-440
70. Shane E, Papadopoulos A, Staron RB, Addesso V, Donovan D, McGregor C, Schulman LL 1999 Bone loss and fracture after lung transplantation. Transplantation 68:220-227
71. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD 1991 Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544-550
72. Guo C-Y, Johnson A, Locke TJ, Eastell R 1998 Mechanisms of bone loss after cardiac transplantation. Bone 22:267-271
73. Pichette V, Bonnardeaux A, Prudhomme L, Gagne M, Cardinal J, Ouimet D 1996 Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis 28:105-114
74. Ninkovic M, Skingle SJ, Bearcroft PW, Bishop N, Alexander GJ, Compston JE 2000 Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 12:931-935
75. Shane E, Rivas M, Staron RB, Silverberg SJ, Seibel MJ, Kuiper J, Mancini D, Addesso V, Michler RE, Factor-Litvak P 1996 Fracture after cardiac transplantation: a prospective longitudinal study J Clin Endocrinol Metab 81:1740-1746
76. Leidig-Bruckner G, Hosch S, Dodidou P, Ritschel D, Conradt C, Klose C, Otto G, Lange R, Theilmann L, Zimmerman R, Pritsch M, Ziegler R 2001 Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 357:342-347
77. Vautour LM, Melton III LJ, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT 2004 Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 15:160-167
78. Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, Langman CB, Salinger MH, Sprague SM 1999 Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456-463
79. Ball AM, Gillen DL, Sherrard D, Weiss NS, Emerson SS, Seliger SL, Kestenbaum BR, Stehman-Breen C 2002 Risk of hip fracture among dialysis and renal transplant recipients. JAMA 288:3014-3018
80. Grotz WH, Mundinger FA, Gugel B, Exner V, Kirste G, Schollmeyer PJ 1994 Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients. Transplantation 58:912-915
81. Wolpaw T, Deal CL, Fleming-Brooks S, Bartucci MR, Schulak JA, Hricik DE 1994 Factors influencing vertebral bone density after renal transplantation. Transplantation 58:1186-1189
82. Hardinger KL, Ho B, Schnitzler MA, Desai N, Lowell J, Shenoy S, Chapman W, Crippin JS 2003 Serial measurements of bone density at the lumbar spine do not predict fracture risk after liver transplantation. Liver Transplant 9:857-862
83. Shane E, Addesso V, Namerow PB, McMahon DJ, Lo SH, Staron RB, Zucker M, Pardi S, Maybaum S, Mancini D 2004 Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med 350:767-776
84. Glendenning P, Kent GN, Adler BD, Matz L, Watson I, O'Driscoll GJ, Hurley DM 1999 High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry. Clin Endocrinol (Oxf) 50:347-355
85. Guichelaar MM, Malinchoc M, Sibonga JD, Clarke BL, Hay JE 2003 Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease. J Bone Miner Res 18:2190-2199
86. Vedi S, Ninkovic M, Garrahan NJ, Alexander GJ, Compston JE 2002 Effects of a single infusion of pamidronate prior to liver transplantation: a bone histomorphometric study. Transplant Int 15:290-295
87. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Ordi J, Rimola A, Rodes J, Munoz-Gomez J 2001 Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 12:484-492
88. Vedi S, Greer S, Skingle SJ, Garrahan NJ, Ninkovic M, Alexander GA, Compston JE 1999 Mechanism of bone loss after liver transplantation: a histomorphometric analysis. J Bone Miner Res 14:281-287
89. Monier-Faugere M, Mawad H, Qi Q, Friedler R, Malluche H 2000 High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 11:1093-1099
90. Carlini RG, Rojas E, Weisinger JR, Lopez M, Martinis R, Arminio A, Bellorin-Font E 2000 Bone disease in patients with long-term renal transplantation and normal renal function. Am J Kidney Dis 36:160-166
91. Fan SL, Cunningham J 2001 Bisphosphonates in renal osteodystrophy. Curr Opin Nephrol Hypertens 10:581-588
92. Kidney Disease Outcomes Quality Initiative (K/DOQI) Group 2003 K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(Suppl 3):S12-S28
93. Dodd VA, Staron RB, Papadopoulos A, Evans L, Schulman LL, Jorgensen B, Gerow-Smith R, Shane E 1999 Bone densitometry should be included in the evaluation of candidates for lung transplantation. J Transplant Coord 9:119-123
94. Crippin JS 2001 Bone disease after liver transplantation. Liver Transplant 7:S27-S35
95. Braith RW, Mills J, Welsch MA, Keller JW, Pollock ML 1996 Resistance exercise training restores bone mineral density in heart transplant recipients. J Am Coll Cardiol 28:1471-1477
96. Braith RW, Magyari PM, Fulton MN, Aranda J, Walker T, Hill JA 2003 Resistance exercise training and alendronate reverse glucocorticoid-induced osteoporosis in heart transplant recipients. J Heart Lung Transplant 22:1082-1090
97. Mitchell MJ, Baz MA, Fulton MN, Lisor CF, Braith RW 2003 Resistance training prevents vertebral osteoporosis in lung transplant recipients. Transplantation 76:557-562
98. Trombetti A, Gerbase MW, Spiliopoulos A, Slosman DO, Nicod LP, Rizzoli R 2000 Bone mineral density in lung-transplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate. J Heart Lung Transplant 19:736-743
99. Meys E, Terreaux-Duvert F, Terreaux-Duvert F, Beaume-Six T, Dureau G, Meunier PJ 1993 Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate. Osteoporos Int 3:322-329
100. Talalaj M, Gradowska L, Marcinowska-Suchowierska E, Durlik M, Gaciong Z, Lao M 1996 Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients. Transplant Proc 28:3485-3487
101. Torres A, Garcia S, Gomez A, Gonzalez A, Barrios Y, Concepcion MT, Hernandez D, Garcia JJ, Checa MD, Lorenzo V, Salido E 2004 Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. Kidney Int 65:705-712
102. Cremer J, Struber M, Wagenbreth I, Nischelsky J, Demertzis S, Graeter T, Abraham C, Haverich A 1999 progression of steroid-associated osteoporosis after heart transplantation. Ann Thoracic Surg 67:130-133
103. Sambrook P, Henderson NK, Keogh A, MacDonald P, Glanville A, Spratt P, Bergin P, Ebeling P, Eisman J 2000 Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Miner Res 15:1818-1824
104. Garcia-Delgado I, Prieto S, Gil-Fraguas L, Robles E, Rufilanchas JJ, Hawkins F 1997 Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation Calcif Tissue Int 60:155-159
105. Hay JE, Malinchoc M, Dickson ER 2001 A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 34:292-298
106. Fan SLS, Almond MK, Ball E, Evans K, Cunningham J 2000 Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 57:684-690
107. Fan SLS, Kumar S, Cunningham J 2003 Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation. Kidney Int 63:2275-2279
108. Aris RM, Lester GE, Renner JB, Winders A, Denene Blackwood A, Lark RK, Ontjes DA 2000 Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 162:941-946
109. Krieg MA, Seydoux C, Sandini L, Goy JJ, Berguer DG, Thiebaud D, Burckhardt P 2001 Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study. Osteoporos Int 12:112-116
110. Reeves HL, Francis RM, Manas DM, Hudson M, Day CP 1998 Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation. Liver Transplant Surg 4:404-409
111. Ninkovic M, Love S, Tom BDM, Bearcroft PWP, Alexander GJM, Compston JE 2002 Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation. J Hepatol 37:93-100
112. Coco M, Glicklich D, Faugere MC, Burris L, Bognar I, Durkin P, Tellis V, Greenstein S, Schechner R, Figueroa K, McDonough P, Wang G, Malluche H 2003 Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol 14:2669-2676
113. Kovac D, Lindic J, Kandus A, Bren AF 2001 Prevention of bone loss in kidney graft recipients. Transplant Proc 33:1144-1145
114. Schwarz C, Mitterbauer C, Heinze G, Woloszczuk W, Haas M, Oberbauer R 2004 Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation. Kidney Int 65:304-309
115. Hommann M, Abendroth K, Lehmann G, Patzer N, Kornberg A, Voigt R, Seifert S, Hein G, Scheele J 2002 Effect of transplantation on bone: osteoporosis after liver and multivisceral transplantation. Transplant Proc 34:2296-2298
116. Grotz W, Nagel C, Poeschel D, Cybulla M, Petersen KG, Uhl M, Strey C, Kirste G, Olschewski M, Reichelt A, Rump LC 2001 Effect of ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 12:1530-1537
117. Ugur A, Guvener N, Isiklar I, Karakayali H, Erdal R 2000 Efficiency of preventive treatment for osteoporosis after renal transplantation. Transplant Proc 32:556-557
118. Cueto-Manzano AM, Konel S, Freemont AJ, Adams JE, Mawer B, Gokal R, Hutchison AJ 2000 Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation. Am J Kidney Dis 35:227-236
119. Stempfle HU, Werner C, Siebert U, Assum T, Wehr U, Rambeck WA, Meiser B, Theisen K, Gartner R 2002 The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 73:547-552
120. Stempfle HU, Werner C, Echtler S, Wehr U, Rambeck WA, Siebert U, Uberfuhr P, Angermann CE, Theisen K, Gartner R 1999 Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 68:523-530
121. Valero MA, Loinaz C, Larrodera L, Leon M, Moreno E, Hawkins F 1995 Calcitonin and bisphosphonates treatment in bone loss after liver transplantation. Calcif Tissue Int 57:15-19
122. Grotz WH, Rump LC, Niessen A, Schmidt-Gayk H, Reichelt A, Kirste G, Olschewski M, Schollmeyer PJ 1998 Treatment of osteopenia and osteoporosis after kidney transplantation. Transplantation 66:1004-1008
123. Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G 2003 Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation. Osteoporos Int 14:82-89
124. Ippoliti G, Pellegrini C, Campana C, Rinaldi M, D'Armini A, Goggi C, Aiello M, Vigano M 2003 Clodronate treatment of established bone loss in cardiac recipients: a randomized study. Transplantation 15:330-334
125. Giannini S, Dangel A, Carraro G, Nobile M, Rigotti P, Bonfante L, Marchini F, Zaninotto M, Dalle Carbonare L, Sartori L, Crepaldi G 2001 Alendronate prevents further bone loss in renal transplant recipients. J Bone Miner Res 16:2111-2117
126. Koc M, Tuglular S, Arikan H, Ozener C, Akoglu E 2002 Alendronate increases bone mineral density in long-term renal transplant recipients. Transplant Proc 34:2111-2113
127. Jeffery JR, Leslie WD, Karpinski ME, Nickerson PW, Rush DN 2003 Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate. Transplantation 76:1498-1502
128. Cruz DN, Brickel HM, Wysolmerski JJ, Gundberg CG, Simpson CA, Kliger AS, Lorber MI, Basadonna GP, Friedman AL, Insogna KL, Bia MJ 2002 Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate. Am J Transplant 2:62-67
129. Isoniemi H, Appelberg J, Nilsson CG, Makela P, Risteli J, Hockerstedt K 2001 Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up study. J Hepatol 34:299-305
130. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
131. Rhoden EL, Morgentaler A 2004 Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 350:482-492
132. Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD 1998 Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 102:1627-1633
133. Marsh C 2002 Calcineurin-sparing or steroid-sparing immunosuppression in renal transplantation. Curr Opin Organ Transplant 7:145-156
134. Martinez G, Gomez R, Jodar E, Loinaz C, Moreno E, Hawkins E 2002 Long-term follow-up of bone mass after orthotopic liver transplantation: effect of steroid withdrawal from the immunosuppressive regimen. Osteoporos Int 13:147-150
135. Nowacka-Cieciura E, Durlik M, Cieciura T, Talalaj M, Kukula K, Lewandowska D, Galazka Z, Lao M, Rowinski W 2001 Positive effect of steroid withdrawal on bone mineral density in renal allograft recipients. Transplant Proc 33:1273-1277
136. O'Shaughnessy EA, Dahl DC, Smith CL, Kasiske BL 2002 Risk factors for fractures in kidney transplantation. Transplantation 74:362-366
137. Taylor DO, Barr ML, Radovancevic B, Renlund DG, Mentzer Jr RM, Smart FW, Tolman DE, Frazier OH, Young JB, VanVeldhuisen P 1999 A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 18:336-345